Literature DB >> 33838322

Loss of function of lysosomal acid lipase (LAL) profoundly impacts osteoblastogenesis and increases fracture risk in humans.

Ron C Helderman1, Daniel G Whitney2, Madalina Duta-Mare3, Alena Akhmetshina3, Nemanja Vujic3, Shobana Jayapalan4, Jeffry S Nyman5, Biswapriya B Misra6, Clifford J Rosen7, Michael P Czech8, Dagmar Kratky9, Elizabeth Rendina-Ruedy10.   

Abstract

Lysosomal acid lipase (LAL) is essential for cholesteryl ester (CE) and triacylglycerol (TAG) hydrolysis in the lysosome. Clinically, an autosomal recessive LIPA mutation causes LAL deficiency (LALD), previously described as Wolman Disease or Cholesteryl Ester Storage Disease (CESD). LAL-D is associated with ectopic lipid accumulation in the liver, small intestine, spleen, adrenal glands, and blood. Considering the importance of unesterified cholesterol and fatty acids in bone metabolism, we hypothesized that LAL is essential for bone formation, and ultimately, skeletal health. To investigate the role of LAL in skeletal homeostasis, we used LAL-deficient (-/-) mice, in vitro osteoblast cultures, and novel clinical data from LAL-D patients. Both male and female LAL-/- mice demonstarted lower trabecular and cortical bone parameters , which translated to reduced biomechanical properties. Further histological analyses revealed that LAL-/- mice had fewer osteoblasts, with no change in osteoclast or marrow adipocyte numbers. In studying the cell-autonomous role of LAL, we observed impaired differentiation of LAL-/- calvarial osteoblasts and in bone marrow stromal cells treated with the LAL inhibitor lalistat. Consistent with LAL's role in other tissues, lalistat resulted in profound lipid puncta accumulation and an altered intracellular lipid profile. Finally, we analyzed a large de-identified national insurance database (i.e. 2016/2017 Optum Clinformatics®) which revealed that adults (≥18 years) with CESD (n = 3076) had a higher odds ratio (OR = 1.21; 95% CI = 1.03-1.41) of all-cause fracture at any location compared to adults without CESD (n = 13.7 M) after adjusting for demographic variables and osteoporosis. These data demonstrate that alterations in LAL have significant clinical implications related to fracture risk and that LAL's modulation of lipid metabolism is a critical for osteoblast function.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; Cholesterol; Lipid; Lipophagy; Metabolism; Osteoblast; Skeleton

Mesh:

Substances:

Year:  2021        PMID: 33838322      PMCID: PMC8108562          DOI: 10.1016/j.bone.2021.115946

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.626


  39 in total

1.  MetaMapR: pathway independent metabolomic network analysis incorporating unknowns.

Authors:  Dmitry Grapov; Kwanjeera Wanichthanarak; Oliver Fiehn
Journal:  Bioinformatics       Date:  2015-04-05       Impact factor: 6.937

2.  Intracellular lipid droplets support osteoblast function.

Authors:  Elizabeth Rendina-Ruedy; Anyonya R Guntur; Clifford J Rosen
Journal:  Adipocyte       Date:  2017-07-20       Impact factor: 4.534

3.  Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia?

Authors:  Joana Rita Chora; Ana Catarina Alves; Ana Margarida Medeiros; Cibelle Mariano; Goreti Lobarinhas; António Guerra; Helena Mansilha; Helena Cortez-Pinto; Mafalda Bourbon
Journal:  J Clin Lipidol       Date:  2016-11-17       Impact factor: 4.766

Review 4.  Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases.

Authors:  Anthony F Porto
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

5.  Mouse lysosomal acid lipase: characterization of the gene and analysis of promoter activity.

Authors:  H Du; M Duanmu; L R Rosa
Journal:  Gene       Date:  1998-02-27       Impact factor: 3.688

Review 6.  Lysosomal acid lipase and lipid metabolism: new mechanisms, new questions, and new therapies.

Authors:  Hanrui Zhang
Journal:  Curr Opin Lipidol       Date:  2018-06       Impact factor: 4.776

7.  Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage.

Authors:  H Du; M Duanmu; D Witte; G A Grabowski
Journal:  Hum Mol Genet       Date:  1998-09       Impact factor: 6.150

Review 8.  Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease.

Authors:  H Du; S Sheriff; J Bezerra; T Leonova; G A Grabowski
Journal:  Mol Genet Metab       Date:  1998-06       Impact factor: 4.797

9.  Specific Substrate for the Assay of Lysosomal Acid Lipase.

Authors:  Sophia Masi; Naveen Chennamaneni; Frantisek Turecek; C Ronald Scott; Michael H Gelb
Journal:  Clin Chem       Date:  2018-01-16       Impact factor: 8.327

Review 10.  Lipids in the Bone Marrow: An Evolving Perspective.

Authors:  Elizabeth Rendina-Ruedy; Clifford J Rosen
Journal:  Cell Metab       Date:  2019-10-24       Impact factor: 27.287

View more
  1 in total

1.  Therapeutic efficacy of rscAAVrh74.miniCMV.LIPA gene therapy in a mouse model of lysosomal acid lipase deficiency.

Authors:  Patricia Lam; Anna Ashbrook; Deborah A Zygmunt; Cong Yan; Hong Du; Paul T Martin
Journal:  Mol Ther Methods Clin Dev       Date:  2022-08-04       Impact factor: 5.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.